Asia-Pacific Syndromic Multiplex Diagnostic Market - Industry Trends and Forecast to 2027

Asia-Pacific syndromic multiplex diagnostic market is projected to register a CAGR of 8.4% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Asia-Pacific Syndromic Multiplex Diagnostic Market, By Products and Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Infection Type (Viral, Bacterial, Parasites, Fungal & Others), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Hepatitis, Tropical Fever, Meningitis, Childhood Infections, Immunosuppression & Eye Infections), Panels Type (Respiratory Panel, GI-Enteric Panel, Sexually Transmitted Disease Panel, Blood-Sepsis Panel, Meningitis Panel & Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Physician Office Lab's & Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines & Rest of Asia-Pacific) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Asia-Pacific syndromic multiplex diagnostic market are:

Rising geriatric population in the region

Growing prevalence of infection diseases

Market Players:

The key market players for Asia-Pacific syndromic multiplex diagnostic market are listed below:

GenMark Diagnostics, Inc.

QuantuMDx Group Ltd.

BioFire Diagnostics (a subsidiary of bioMerieux SA)

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

QIAGEN

Hologic, Inc.

F. Hoffmann-La Roche Ltd

BD

Danaher

Curetis

Abbott

DiaSorin S.p.A.

Bosch Healthcare Solutions GmbH (a subsidiary of Robert Bosch GmbH)

Biocartis

Luminex Corporation

Seegene Inc.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 OBJECTIVES OF THE STUDY
• 1.2 MARKET DEFINITION
• 1.3 OVERVIEW OF ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET
• 1.4 LIMITATIONS
• 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

• 2.1 MARKETS COVERED
• 2.2 GEOGRAPHICAL SCOPE
• 2.3 YEARS CONSIDERED FOR THE STUDY
• 2.4 CURRENCY AND PRICING
• 2.5 DBMR TRIPOD DATA VALIDATION MODEL
• 2.6 MULTIVARIATE MODELLING
• 2.7 PRODUCTS AND SERVICES LIFELINE CURVE
• 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
• 2.9 DBMR MARKET POSITION GRID
• 2.10 VENDOR SHARE ANALYSIS
• 2.11 SECONDARY SOURCES
• 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

• 5.1 DRIVERS
  • 5.1.1 GROWING PREVALENCE OF INFECTION DISEASES
  • 5.1.2 GROWING ADOPTION OF MOLECULAR DIAGNOSTICS
  • 5.1.3 INCREASING REGULATORY APPROVAL FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) TESTING
  • 5.1.4 INCREASING DEMAND FOR ACCURATE AND FAST DIAGNOSTIC RESULTS
  • 5.1.5 IMPROVING DIAGNOSIS SEEKING RATE
• 5.2 RESTRAINTS
  • 5.2.1 HIGH COST OF DIAGNOSTIC PRODUCTS
  • 5.2.2 EXPLICIT LIMITATION OF SYNDROMIC MULTIPLEX DIAGNOSTIC
• 5.3 OPPORTUNITIES
  • 5.3.1 INCREASING DIAGNOSTIC HEALTHCARE EXPENDITURE
  • 5.3.2 INTRODUCTION OF TECHNOLOGICALLY ADVANCED PRODUCTS
• 5.4 CHALLENGES
  • 5.4.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF DIAGNOSTIC PRODUCTS
  • 5.4.2 LACK OF SKILLED PROFESSIONALS AND BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS

6 IMPACT OF COVID-19 ON ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

• 6.1 IMPACT ANALYSIS ON DEMAND
• 6.2 CONCLUSION

7 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES

• 7.1 OVERVIEW
• 7.2 REAGENTS & CONSUMABLES
• 7.3 INSTRUMENTS & ACCESSORIES
• 7.4 SOFTWARE & SERVICES

8 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE

• 8.1 OVERVIEW
• 8.2 VIRAL
  • 8.2.1 RHINOVIRUS
  • 8.2.2 ROTAVIRUS
  • 8.2.3 ADENOVIRUS
  • 8.2.4 CORONAVIRUS
  • 8.2.5 OTHERS
• 8.3 BACTERIAL
  • 8.3.1 PNEUMONIAE
  • 8.3.2 BORDETELLA PERTUSSIS
  • 8.3.3 STAPHYLOCOCCUS
  • 8.3.4 OF OTHERS
• 8.4 PARASITES
• 8.5 FUNGAL
• 8.6 OTHERS

9 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE

• 9.1 OVERVIEW
• 9.2 RESPIRATORY INFECTIONS
• 9.3 GASTROENTERITIS
• 9.4 SEXUALLY TRANSMITTED INFECTIONS
• 9.5 HEPATITIS
• 9.6 TROPICAL FEVER
• 9.7 MENINGITIS
• 9.8 CHILDHOOD INFECTIONS
• 9.9 IMMUNOSUPPRESSION
• 9.10 EYE INFECTIONS

10 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE

• 10.1 OVERVIEW
• 10.2 RESPIRATORY PANEL
• 10.3 GI-ENTERIC PANEL
• 10.4 SEXUALLY TRANSMITTED DISEASE PANEL
• 10.5 BLOOD-SEPSIS PANEL
• 10.6 MENINGITIS PANEL
• 10.7 OTHERS

11 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER

• 11.1 OVERVIEW
• 11.2 HOSPITALS
• 11.3 CLINICAL LABORATORIES
• 11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
• 11.5 RESEARCH INSTITUTES
• 11.6 PHYSICIAN OFFICE LAB'S
• 11.7 OTHERS

12 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY GEOGRAPHY

• 12.1 ASIA-PACIFIC
  • 12.1.1 CHINA
  • 12.1.2 JAPAN
  • 12.1.3 INDIA `
  • 12.1.4 SOUTH KOREA
  • 12.1.5 AUSTRALIA
  • 12.1.6 SINGAPORE
  • 12.1.7 THAILAND
  • 12.1.8 MALAYSIA
  • 12.1.9 INDONESIA
  • 12.1.10 PHILIPPINES
  • 12.1.11 REST OF ASIA-PACIFIC

 

13 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, COMPANY LANDSCAPE

• 13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14 SWOT ANALYSIS

15 COMPANY PROFILE

• 15.1 BIOFIRE DIAGNOSTICS (A SUBSIDIARY OF BIOMERIEUX SA)
  • 15.1.1 COMPANY SNAPSHOT
  • 15.1.2 REVENUE ANALYSIS
  • 15.1.3 COMPANY SHARE ANALYSIS
  • 15.1.4 PRODUCT PORTFOLIO
  • 15.1.5 RECENT DEVELOPMENTS
• 15.2 SIEMENS HEALTHCARE GMBH
  • 15.2.1 COMPANY SNAPSHOT
  • 15.2.2 REVENUE ANALYSIS
  • 15.2.3 COMPANY SHARE ANALYSIS
  • 15.2.4 PRODUCT PORTFOLIO
  • 15.2.5 RECENT DEVELOPMENTS
• 15.3 F. HOFFMANN-LA ROCHE LTD
  • 15.3.1 COMPANY SNAPSHOT
  • 15.3.2 REVENUE ANALYSIS
  • 15.3.3 COMPANY SHARE ANALYSIS
  • 15.3.4 PRODUCT PORTFOLIO
  • 15.3.5 RECENT DEVELOPMENT
• 15.4 THERMO FISHER SCIENTIFIC INC.
  • 15.4.1 COMPANY SNAPSHOT
  • 15.4.2 REVENUE ANALYSIS
  • 15.4.3 COMPANY SHARE ANALYSIS
  • 15.4.4 PRODUCT PORTFOLIO
  • 15.4.5 RECENT DEVELOPMENT
• 15.5 BD
  • 15.5.1 COMPANY SNAPSHOT
  • 15.5.2 REVENUE ANALYSIS
  • 15.5.3 COMPANY SHARE ANALYSIS
  • 15.5.4 PRODUCT PORTFOLIO
  • 15.5.5 RECENT DEVELOPMENTS

 

• 15.6 SEEGENE INC.
  • 15.6.1 COMPANY SNAPSHOT
  • 15.6.2 REVENUE ANALYSIS
  • 15.6.3 PRODUCT PORTFOLIO
  • 15.6.4 RECENT DEVELOPMENTS
• 15.7 ABBOTT
  • 15.7.1 COMPANY SNAPSHOT
  • 15.7.2 REVENUE ANALYSIS
  • 15.7.3 PRODUCT PORTFOLIO
  • 15.7.4 RECENT DEVELOPMENT
• 15.8 APPLIED BIOCODE, INC.
  • 15.8.1 COMPANY SNAPSHOT
  • 15.8.2 PRODUCT PORTFOLIO
  • 15.8.3 RECENT DEVELOPMENTS
• 15.9 BIOCARTIS
  • 15.9.1 COMPANY SNAPSHOT
  • 15.9.2 REVENUE ANALYSIS
  • 15.9.3 PRODUCT PORTFOLIO
  • 15.9.4 RECENT DEVELOPMENT
• 15.10 BIO-RAD LABORATORIES, INC.
  • 15.10.1 COMPANY SNAPSHOT
  • 15.10.2 REVENUE ANALYSIS
  • 15.10.3 PRODUCT PORTFOLIO
  • 15.10.4 RECENT DEVELOPMENT
• 15.11 BOSCH HEALTHCARE SOLUTIONS GMBH (A SUBSIDIARY OF ROBERT BOSCH GMBH)
  • 15.11.1 COMPANY SNAPSHOT
  • 15.11.2 REVENUE ANALYSIS
  • 15.11.3 PRODUCT PORTFOLIO
  • 15.11.4 RECENT DEVELOPMENT
• 15.12 CURETIS
  • 15.12.1 COMPANY SNAPSHOT
  • 15.12.2 PRODUCT PORTFOLIO
  • 15.12.3 RECENT DEVELOPMENT
• 15.13 DANAHER
  • 15.13.1 COMPANY SNAPSHOT
  • 15.13.2 REVENUE ANALYSIS
  • 15.13.3 PRODUCT PORTFOLIO
  • 15.13.4 RECENT DEVELOPMENT

 

• 15.14 DIASORIN S.P.A.
  • 15.14.1 COMPANY SNAPSHOT
  • 15.14.2 REVENUE ANALYSIS
  • 15.14.3 PRODUCT PORTFOLIO
  • 15.14.4 RECENT DEVELOPMENTS
• 15.15 GENMARK DIAGNOSTICS, INC.
  • 15.15.1 COMPANY SNAPSHOT
  • 15.15.2 REVENUE ANALYSIS
  • 15.15.3 PRODUCT PORTFOLIO
  • 15.15.4 RECENT DEVELOPMENTS
• 15.16 HOLOGIC, INC.
  • 15.16.1 COMPANY SNAPSHOT
  • 15.16.2 REVENUE ANALYSIS
  • 15.16.3 PRODUCT PORTFOLIO
  • 15.16.4 RECENT DEVELOPMENTS
• 15.17 LUMINEX CORPORATION
  • 15.17.1 COMPANY SNAPSHOT
  • 15.17.2 REVENUE ANALYSIS
  • 15.17.3 PRODUCT PORTFOLIO
  • 15.17.4 RECENT DEVELOPMENT
• 15.18 NANOMIX, INC.
  • 15.18.1 COMPANY SNAPSHOT
  • 15.18.2 PRODUCT PORTFOLIO
  • 15.18.3 RECENT DEVELOPMENTS
• 15.19 PROMINEX
  • 15.19.1 COMPANY SNAPSHOT
  • 15.19.2 PRODUCT PORTFOLIO
  • 15.19.3 RECENT DEVELOPMENT
• 15.20 QIAGEN
  • 15.20.1 COMPANY SNAPSHOT
  • 15.20.2 REVENUE ANALYSIS
  • 15.20.3 PRODUCT PORTFOLIO
  • 15.20.4 RECENT DEVELOPMENT
• 15.21 QUANTUMDX GROUP LTD.
  • 15.21.1 COMPANY SNAPSHOT
  • 15.21.2 PRODUCT PORTFOLIO
  • 15.21.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF TABLES

• TABLE 1 COST OF THE PRODUCT
• TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
• TABLE 3 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 4 ASIA-PACIFIC REAGENTS & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 5 ASIA-PACIFIC INSTRUMENTS & ACCESSORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 6 ASIA-PACIFIC SOFTWARE & SERVICES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 7 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 8 ASIA-PACIFIC VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 9 ASIA-PACIFIC VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 10 ASIA-PACIFIC BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 11 ASIA-PACIFIC BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 12 ASIA-PACIFIC PARASITES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 13 ASIA-PACIFIC FUNGAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 14 ASIA-PACIFIC OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 15 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 16 ASIA-PACIFIC RESPIRATORY INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 17 ASIA-PACIFIC GASTROENTERITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 18 ASIA-PACIFIC SEXUALLY TRANSMITTED INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 19 ASIA-PACIFIC HEPATITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 20 ASIA-PACIFIC TROPICAL FEVER IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 21 ASIA-PACIFIC MENINGITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 22 ASIA-PACIFIC CHILDHOOD INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 23 ASIA-PACIFIC IMMUNOSUPPRESSION IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 24 ASIA-PACIFIC EYE INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 25 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, LIFELINE CURVE, 2018-2027 (USD MILLION)
• TABLE 26 ASIA-PACIFIC RESPIRATORY PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 27 ASIA-PACIFIC GI-ENTERIC PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 28 ASIA-PACIFIC SEXUALLY TRANSMITTED DISEASE PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 29 ASIA-PACIFIC BLOOD-SEPSIS PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 30 ASIA-PACIFIC MENINGITIS PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 31 ASIA-PACIFIC OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 32 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 33 ASIA-PACIFIC HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 34 ASIA-PACIFIC CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 35 ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 36 ASIA-PACIFIC RESEARCH INSTITUTES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 37 ASIA-PACIFIC PHYSICIAN OFFICE LAB'S IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 38 ASIA-PACIFIC OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)
• TABLE 39 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
• TABLE 40 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 41 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 42 ASIA-PACIFIC VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 43 ASIA-PACIFIC BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 44 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 45 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 46 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 47 CHINA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 48 CHINA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 49 CHINA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 50 CHINA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 51 CHINA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 52 CHINA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 53 CHINA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 54 JAPAN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 55 JAPAN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 56 JAPAN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 57 JAPAN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 58 JAPAN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 59 JAPAN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 60 JAPAN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 61 INDIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 62 INDIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 63 INDIA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 64 INDIA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 65 INDIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 66 INDIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 67 INDIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 68 SOUTH KOREA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 69 SOUTH KOREA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 70 SOUTH KOREA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 71 SOUTH KOREA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 72 SOUTH KOREA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 73 SOUTH KOREA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 74 SOUTH KOREA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 75 AUSTRALIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 76 AUSTRALIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 77 AUSTRALIA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 78 AUSTRALIA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 79 AUSTRALIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 80 AUSTRALIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 81 AUSTRALIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 82 SINGAPORE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 83 SINGAPORE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 84 SINGAPORE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 85 SINGAPORE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 86 SINGAPORE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 87 SINGAPORE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 88 SINGAPORE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 89 THAILAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 90 THAILAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 91 THAILAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 92 THAILAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 93 THAILAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 94 THAILAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 95 THAILAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 96 MALAYSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 97 MALAYSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 98 MALAYSIA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 99 MALAYSIA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 100 MALAYSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 101 MALAYSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 102 MALAYSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 103 INDONESIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 104 INDONESIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 105 INDONESIA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 106 INDONESIA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 107 INDONESIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 108 INDONESIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 109 INDONESIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 110 PHILIPPINES SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
• TABLE 111 PHILIPPINES SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 112 PHILIPPINES VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 113 PHILIPPINES BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)
• TABLE 114 PHILIPPINES SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)
• TABLE 115 PHILIPPINES SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)
• TABLE 116 PHILIPPINES SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)
• TABLE 117 PHILIPPINES SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)

LIST OF FIGURES

• FIGURE 1 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION
• FIGURE 2 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DATA TRIANGULATION
• FIGURE 3 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DROC ANALYSIS
• FIGURE 4 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET : ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
• FIGURE 5 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET : COMPANY RESEARCH ANALYSIS
• FIGURE 6 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS
• FIGURE 7 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID
• FIGURE 8 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS
• FIGURE 9 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION
• FIGURE 10 GROWING PREVALENCE OF INFECTION DISEASES AND GROWING ADOPTION OF MOLECULAR DIAGNOSTICS ARE EXPECTED TO DRIVE THE ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
• FIGURE 11 REAGENTS & CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN 2020 & 2027
• FIGURE 12 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR SYNDROMIC MULTIPLEX DIAGNOSTIC MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027
• FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET
• FIGURE 14 PREVALENCE OF CHRONIC DISEASES
• FIGURE 15 PERCENTAGE OF DEATHS WORLDWIDE
• FIGURE 16 TOTAL CASES OF CORONAVIRUS IN NORTH AMERICA
• FIGURE 17 TOTAL CASES OF CORONAVIRUS IN EUROPE
• FIGURE 18 TOTAL CASES OF CORONAVIRUS IN ASIA-PACIFIC
• FIGURE 19 TOTAL CASES OF CORONAVIRUS IN SOUTH AMERICA
• FIGURE 20 TOTAL CASES OF CORONAVIRUS IN MIDDLE EAST AND AFRICA
• FIGURE 21 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS
• FIGURE 22 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, 2019
• FIGURE 23 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, 2019-2027 (USD MILLION)
• FIGURE 24 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, CAGR (2020-2027)
• FIGURE 25 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE
• FIGURE 26 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2019
• FIGURE 27 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2019-2027 (USD MILLION)
• FIGURE 28 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, CAGR (2020-2027)
• FIGURE 29 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, LIFELINE CURVE
• FIGURE 30 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2019
• FIGURE 31 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2019-2027 (USD MILLION)
• FIGURE 32 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, CAGR (2020-2027)
• FIGURE 33 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, LIFELINE CURVE
• FIGURE 34 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, 2019
• FIGURE 35 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, 2019-2027 (USD MILLION)
• FIGURE 36 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, CAGR (2020-2027)
• FIGURE 37 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, LIFELINE CURVE
• FIGURE 38 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2019
• FIGURE 39 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2019-2027 (USD MILLION)
• FIGURE 40 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, CAGR (2020-2027)
• FIGURE 41 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE
• FIGURE 42 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SNAPSHOT (2019)
• FIGURE 43 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2019)
• FIGURE 44 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2020 & 2027)
• FIGURE 45 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2020 & 2027)
• FIGURE 46 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES (2018-2027)
• FIGURE 47 ASIA-PACIFIC SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY SHARE 2019 (%)